Targeted next generation sequencing (NGS) for evaluating PI3/AKT/mTOR pathway as a potential therapeutic target for triple negative breast cancer

Accessibility Controls

Principal Investigator

Dr. Amanjit Bal

Professor, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh

Area of Research

Medical Sciences

Focus Area

Triple negative breast cancer

Start Date

2017

Sanction Amount

₹ 63.33 L

Contact

bal.amanjit@pgimer.edu.in

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls